Skip to content

NYIAX, Inc.: 10-Q filed 2025-02-19

What NYIAX, Inc. reported in its quarterly report filed 2025-02-19 (fiscal Q3 2024): 34 published measures, 108 facts as tagged in accession 0001213900-25-015062.

This filing

Form
10-Q (quarterly report)
Filed
2025-02-19
Fiscal period
fiscal Q3 2024
Accession
0001213900-25-015062 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NYIAX, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-30438,737USD
At 2023-12-314,244,847USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-309,731,499USD
At 2023-12-317,976,246USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-30-9,292,762USD
At 2024-06-30-5,406,910USD
At 2024-03-31-4,498,462USD
At 2023-12-31-3,731,399USD
At 2023-09-30-2,769,225USD
At 2023-06-30-4,759,386USD
At 2023-03-31-3,322,545USD
At 2022-12-31-3,228,169USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-30294,054USD
At 2023-12-3155,014USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-4,164,646USD92
2024-01-01 to 2024-09-30-6,900,025USD274
2024-04-01 to 2024-06-30-1,359,586USD91
2024-01-01 to 2024-03-31-1,375,794USD91
2023-07-01 to 2023-09-30-2,145,972USD92
2023-01-01 to 2023-09-30-7,425,238USD273
2023-04-01 to 2023-06-30-2,291,283USD91
2023-01-01 to 2023-03-31-2,987,985USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-1,610,960USD274
2023-01-01 to 2023-09-30-2,793,551USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-07-01 to 2024-09-3077,245USD92
2024-01-01 to 2024-09-30242,100USD274
2023-07-01 to 2023-09-3097,820USD92
2023-01-01 to 2023-09-30324,835USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-301,850,000USD274
2023-01-01 to 2023-09-302,170,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-68,525,255USD
At 2023-12-31-61,977,715USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-3015,690,719shares92
2024-01-01 to 2024-09-3015,675,388shares274
2023-07-01 to 2023-09-3015,410,961shares92
2023-01-01 to 2023-09-3014,043,190shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2024-09-3015,690,719shares92
2024-01-01 to 2024-09-3015,675,388shares274
2023-07-01 to 2023-09-3015,410,961shares92
2023-01-01 to 2023-09-3014,043,190shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.27USD/shares92
2024-01-01 to 2024-09-30-0.44USD/shares274
2023-07-01 to 2023-09-30-0.14USD/shares92
2023-01-01 to 2023-09-30-0.53USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.27USD/shares92
2024-01-01 to 2024-09-30-0.44USD/shares274
2023-07-01 to 2023-09-30-0.14USD/shares92
2023-01-01 to 2023-09-30-0.53USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-09-301,566USD
At 2023-12-312,196USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-09-30372,191USD274
2023-01-01 to 2023-09-30443,868USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-4,003,355USD92
2024-01-01 to 2024-09-30-6,529,985USD274
2023-07-01 to 2023-09-30-1,693,963USD92
2023-01-01 to 2023-09-30-6,525,749USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-30388,037USD
At 2023-12-31322,602USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-309,731,497USD
At 2023-12-317,883,446USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-12-313,404,958USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-09-3072,668USD
At 2023-12-31262,588USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2024-09-303,939,485USD92
2024-01-01 to 2024-09-306,320,402USD274
2023-07-01 to 2023-09-301,632,343USD92
2023-01-01 to 2023-09-306,300,500USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-63,870USD92
2024-01-01 to 2024-09-30-209,583USD274
2023-07-01 to 2023-09-30-61,620USD92
2023-01-01 to 2023-09-30-225,249USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-07-01 to 2024-09-30141,115USD92
2024-01-01 to 2024-09-30451,683USD274
2023-07-01 to 2023-09-30159,440USD92
2023-01-01 to 2023-09-30550,084USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,055,937USD92
2024-01-01 to 2024-09-302,869,642USD274
2023-07-01 to 2023-09-301,048,353USD92
2023-01-01 to 2023-09-304,356,987USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-07-01 to 2024-09-3073,421USD92
2024-01-01 to 2024-09-30398,467USD274
2023-07-01 to 2023-09-30299,007USD92
2023-01-01 to 2023-09-30986,669USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-09-3015,690,719shares
At 2023-12-3115,611,827shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-09-30294,054USD
At 2023-12-3155,014USD
At 2023-09-30168,786USD
At 2022-12-31792,337USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-09-3059,230,922USD
At 2023-12-3158,244,754USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-12-31244,451USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-4,164,646USD92
2024-01-01 to 2024-09-30-6,900,025USD274
2023-07-01 to 2023-09-30-2,145,972USD92
2023-01-01 to 2023-09-30-7,425,238USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-01-01 to 2024-09-301,040,631USD274
2023-01-01 to 2023-09-30446,071USD273

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-07-01 to 2024-09-30161,291USD92
2024-01-01 to 2024-09-30370,040USD274
2023-07-01 to 2023-09-30452,009USD92
2023-01-01 to 2023-09-30899,489USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-161,291USD92
2024-01-01 to 2024-09-30-370,040USD274
2023-07-01 to 2023-09-30-452,009USD92
2023-01-01 to 2023-09-30-899,489USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-189,918USD274
2023-01-01 to 2023-09-30-1,760,827USD273

Inspect the source

Entity
NYIAX, Inc. / CIK 0001679379
Captured
2026-09-21T17:23:06.196Z
SEC response SHA-256
6fe33c37905348481dc874c5740086903312c7fd3c354c588d8b0a8e5461fe03

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001679379.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))